Breaking News

5 analyst picks of the day: Nike upped on Q3 beat | Pro Recap

Davit KirakosyanStock Markets

Published Mar 24, 2023 04:56AM ET Updated Mar 24, 2023 11:47AM ET

Saved. See Saved Items.

This article has already been saved in your Saved Items

5 analyst picks of the day: Nike upped on Q3 beat | Pro Recap

NKE

-0.32%

Add to/Remove from Watchlist

PXD

-1.08%

Add to/Remove from Watchlist

REGN

-0.48%

Add to/Remove from Watchlist

FIVN

+1.47%

Add to/Remove from Watchlist

ACCD

-0.60%

Add to/Remove from Watchlist

By Davit Kirakosyan

Investnig.com -- Here is your daily Pro Recap of the biggest analyst upgrades you may have missed since yesterday.

Nike upgraded at Barclays on a high probability of margin upside

Barclays upgraded Nike (NYSE:NKE) to Overweight from Equalweight and raised its price target to $154.00 from $110.00 on its belief in a high probability of margin upside.

“Combining improving freight relief as we enter FY24 with reduced promotional pressure, we believe the visibility on gross margin recapture is significantly improved,” said the firm.

The company reported its Q3 earnings results on Tuesday, which, according to Barclays, demonstrated the company’s “broad-based brand strength in spite of a weakening consumer macro backdrop.”

Q3 EPS came in at $0.79, better than the consensus estimate of $0.55. Revenue was $12.4 billion, beating the consensus estimate of $11.47B. The company expects fiscal 2023 revenue to grow high single-digits, an improvement from mid-single-digit guidance in the prior quarter.

As always, InvestingPro subscribers got this news in real time. Get faster headlines for better, data-driven decisions.

Two analysts upgraded Regeneron Pharma following a positive Dupixent data announcement

Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded at Jefferies and Raymond James after the company announced positive data from the Phase 3 trial evaluating Dupixent in chronic obstructive pulmonary disease (COPD) indication. As a result, shares gained more than 6% yesterday.

Jefferies upgraded the stock to Buy from Hold and raised its price target to $925.00 from $675.00.

Meanwhile, Raymond James upgraded to Market Perform from Underperform as it believes there are limited remaining clinical downside catalysts during 2023, but it does expect the continued debate around the outlook for EYLEA, VABYSMO, and 8mg aflibercept to weigh on the stock.

Accolade upgraded to Buy

Guggenheim upgraded Accolade (NASDAQ:ACCD) to Buy from Neutral with a price target of $16.00. Shares jumped more than 10% yesterday.

“We began warming up to the name after seeing the results of our benefits management survey that highlighted Advocacy/Navigator benefits as an increasing area of focus,” said the firm, adding that the company has had a strong 2022 selling season, demonstrated solid gross revenue retention, and indicated a faster than expected path to cash break even.

With the improved growth outlook and profitability, the firm believes that investors are likely to reward the company with a higher multiple.

2 more picks

Citi upgraded Pioneer Natural Resources (NYSE:PXD) to Buy from Neutral and raised its price target to $210.00 from $193.00. According to the firm, capital efficiency should improve for domestic E&Ps on lower service rates, while Pioneer Natural Resources should also experience rising well productivity in H2/23.

Rosenblatt initiated coverage on Five9 (NASDAQ:FIVN) with a Buy rating and a price target of $85.00.

“The stock is currently trading at 4.8x our FY23 revenue estimate of $0.9B of revenue. We believe the stock deserves to be re-rated at least halfway back to its pre-pandemic range of 10x-12x,” said the firm, noting that this new level would be supported by better growth, profitability and increased exposure to AI/Automation to its product profile and expanding its market reach upmarket and internationally.

Add a Comment

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

Write your thoughts here

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

US 30	33,877.5	+43.9	+0.13%
US 500	4,301.8	+7.9	+0.18%
Dow Jones	33,876.78	+43.17	+0.13%
S&P 500	4,298.86	+4.93	+0.11%
Nasdaq	13,259.14	+20.62	+0.16%
S&P 500 VIX	13.83	+0.00	+0.00%
Dollar Index	103.525	+0.209	+0.20%

Crude Oil WTI	70.35	-0.94	-1.32%
Brent Oil	75.04	-0.92	-1.21%
Natural Gas	2.262	-0.090	-3.83%
Gold	1,975.90	-2.70	-0.14%
Silver	24.395	+0.047	+0.19%
Copper	3.7710	-0.0240	-0.63%
US Soybeans	1,387.75	+24.75	+1.82%

U.S. 10Y	3.743	-0.002	-0.05%
U.S. 30Y	3.883	-0.004	-0.10%
U.S. 5Y	3.915	+-0.003	+-0.09%
U.S. 3M	5.253	-0.011	-0.22%
US 10Y T-Note	113.39	-0.34	-0.30%
Euro Bund	134.12	+0.25	+0.19%
10-2 Yield Spread	-85.43	-5.35	6.68%

Apple	180.96	+0.39	+0.22%
Alphabet A	122.23	+0.09	+0.07%
Tesla	244.40	+9.54	+4.06%
Amazon.com	123.43	-0.82	-0.66%
Netflix	420.02	+10.65	+2.60%
Meta Platforms	264.95	+0.37	+0.14%
Bank of America	29.27	+0.04	+0.14%

5 analyst picks of the day: Nike upped on Q3 beat | Pro Recap

Nike upgraded at Barclays on a high probability of margin upside

Two analysts upgraded Regeneron Pharma following a positive Dupixent data announcement

Accolade upgraded to Buy

2 more picks

Related Articles